-
Je něco špatně v tomto záznamu ?
Celkové riziko úmrtí u pacientů s diabetem mellitem 2. typu na monoterapii glipizidem, glyburidem nebo glimepiridem: retrospektivní analýza
Pantalone K. M., Kattan M. W., Yu C., Wells B. J., Arrigain S., Jain A., Atreja A., Zimmerman R. S.
Diabetology news.
2012 ;
3 (1) :
11.
Status neindexováno Jazyk čeština Země Česko
Typ dokumentu abstrakty
Perzistentní odkaz
https://www.medvik.cz/link/bmc15022499
The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care. 2010 Jun;33(6):1224-1229
- 000
- 00000naa a2200000 a 4500
- 001
- bmc15022499
- 003
- CZ-PrNML
- 005
- 20150715152339.0
- 007
- ta
- 008
- 150702s2012 xr f 00 0|cze||
- 009
- PC
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a cze
- 044 __
- $a xr
- 100 1_
- $a Pantalone, K. M., $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 245 10
- $a Celkové riziko úmrtí u pacientů s diabetem mellitem 2. typu na monoterapii glipizidem, glyburidem nebo glimepiridem: retrospektivní analýza / $c Pantalone K. M., Kattan M. W., Yu C., Wells B. J., Arrigain S., Jain A., Atreja A., Zimmerman R. S.
- 500 __
- $a The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis. Diabetes Care. 2010 Jun;33(6):1224-1229
- 590 __
- $a NEINDEXOVÁNO
- 655 _2
- $a abstrakty $7 D020504
- 700 1_
- $a Kattan, M. W. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 700 1_
- $a Yu, C. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 700 1_
- $a Wells, B. J. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 700 1_
- $a Arrigain, S. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA $7 gn_A_00008873
- 700 1_
- $a Jain, A. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 700 1_
- $a Atreja, A. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA $7 gn_A_00009817
- 700 1_
- $a Zimmerman, R. S. $u Endocrinology and Metabolism Institute, Cleveland Clinic, Cleveland, Ohio, USA
- 773 0_
- $t Diabetology news $x 1804-1647 $g Roč. 3, č. 1 (2012), s. 11 $w MED00182868
- 910 __
- $a ABA008 $b B 2689 $c 136 a $y 4 $z 0
- 990 __
- $a 20150702134900 $b ABA008
- 991 __
- $a 20150715152407 $b ABA008
- 999 __
- $a ok $b bmc $g 1082892 $s 905487
- BAS __
- $a 6
- BMC __
- $a 2012 $b 3 $c 1 $d 11 $i 1804-1647 $m Diabetology news $x MED00182868
- LZP __
- $a NLK 2015-16/mkbi
